Evaluating Endometriosis With 16α-(18)F-fluoro-17β-estradiol ([F-18] FES) PET/MRI

• Status: Enrolling by invitation
• Trial end date: 2022-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

Researchers are trying to improve the detection of endometriosis using F-18 FES PET/MRI imaging.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Annie (Annie) T. Packard

Criteria

Inclusion Criteria:

• Premenopausal women (18-50) with endometriosis

Exclusion Criteria:

• Postmenopausal women

• AP diameter when lying supine greater than 32 cm (too large for PET/MRI)

• Unable to undergo PET/MRI for any reason (metal implants, severe claustrophobia)

• Unable to receive IV Gadolinium contrast for any reason (renal failure eGFR < 60, contrast allergy)

• Pregnant (Urine test will be provided for all patients)